Vault-13

Nextech Invest Ltd.

Zurich, V8 · CIK 1911010 · 13F filing filed 2023-08-14

Exempt reporting adviser since 2022 · other (specify)

As an employer

$294.2m reported value +22.8% vs Q1 2023
13positions
97.8%in top 10
1 new 1 added 1 reduced 0 sold out vs Q1 2023

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 REVOLUTION MEDICINES INC COM RVMD RVMD 4,839,529 $129.5m44.00% 44.00% UnchangedShares held: Q3 2022 4.2m, Q4 2022 4.2m, Q1 2023 4.8m, Q2 2023 4.8m
2 TYRA BIOSCIENCES INC COM TYRA TYRA 2,518,582 $42.9m14.58% 14.58% UnchangedShares held: Q3 2022 2.5m, Q4 2022 2.5m, Q1 2023 2.5m, Q2 2023 2.5m
3 ORIC PHARMACEUTICALS INC COM ORIC ORIC 4,285,714 $33.3m11.30% 11.30% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 4.3m
4 EQRX INC COM COM 13,104,424 $24.4m8.28% 8.28% UnchangedShares held: Q3 2022 13.1m, Q4 2022 13.1m, Q1 2023 13.1m, Q2 2023 13.1m
5 CULLINAN THERAPEUTICS INC COM CGEM CGEM 1,221,145 $13.1m4.47% 4.47% UnchangedShares held: Q3 2022 1.2m, Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 1.2m
6 ARS PHARMACEUTICALS INC COM SPRY SPRY 1,910,029 $12.8m4.35% 4.35% UnchangedShares held: Q3 2022 1.9m, Q4 2022 1.9m, Q1 2023 1.9m, Q2 2023 1.9m
7 RELAY THERAPEUTICS INC COM RLAY RLAY 948,659 $11.9m4.05% 4.05% AddedShares held: Q3 2022 475.5k, Q4 2022 475.5k, Q1 2023 625.5k, Q2 2023 948.7k +323.2k +323,174 51.7%
8 ARVINAS INC COM ARVN ARVN 287,251 $7.1m2.42% 2.42% UnchangedShares held: Q3 2022 287.3k, Q4 2022 287.3k, Q1 2023 287.3k, Q2 2023 287.3k
9 KINNATE BIOPHARMA INC COM KNTE KNTE 2,329,480 $7.1m2.40% 2.40% UnchangedShares held: Q3 2022 2.7m, Q4 2022 2.3m, Q1 2023 2.3m, Q2 2023 2.3m
10 THESEUS PHARMACEUTICALS INC COM COM 611,310 $5.7m1.94% 1.94% UnchangedShares held: Q3 2022 611.3k, Q4 2022 611.3k, Q1 2023 611.3k, Q2 2023 611.3k
11 PMV PHARMACEUTICALS INC COM PMVP PMVP 471,284 $3.0m1.00% 1.00% ReducedShares held: Q3 2022 1.4m, Q4 2022 1.4m, Q1 2023 521.3k, Q2 2023 471.3k -50.0k -50,000 -9.6%
12 KRONOS BIO INC COM KRON KRON 1,451,537 $2.5m0.85% 0.85% UnchangedShares held: Q3 2022 1.5m, Q4 2022 1.5m, Q1 2023 1.5m, Q2 2023 1.5m
13 C4 THERAPEUTICS INC COM STK CCCC CCCC 375,857 $1.0m0.35% 0.35% UnchangedShares held: Q3 2022 375.9k, Q4 2022 375.9k, Q1 2023 375.9k, Q2 2023 375.9k